Cite
B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.
MLA
Zhang, Xiaoling, et al. “B3galt5 Deficiency Attenuates Hepatocellular Carcinoma by Suppressing MTOR/P70s6k-Mediated Glycolysis.” Cellular & Molecular Life Sciences, vol. 80, no. 1, Jan. 2023, pp. 1–20. EBSCOhost, https://doi.org/10.1007/s00018-022-04601-x.
APA
Zhang, X., Liu, H., Wang, H., Zhao, R., Lu, Q., Liu, Y., Han, Y., LuluRen, Pan, H., & Han, W. (2023). B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis. Cellular & Molecular Life Sciences, 80(1), 1–20. https://doi.org/10.1007/s00018-022-04601-x
Chicago
Zhang, Xiaoling, Hao Liu, Haidong Wang, Rongjie Zhao, Qian Lu, Yunlong Liu, Yicheng Han, LuluRen, Hongming Pan, and Weidong Han. 2023. “B3galt5 Deficiency Attenuates Hepatocellular Carcinoma by Suppressing MTOR/P70s6k-Mediated Glycolysis.” Cellular & Molecular Life Sciences 80 (1): 1–20. doi:10.1007/s00018-022-04601-x.